BRIDGEBIO PHARMA, INC. <BBIO.O>: MIZUHO RAISES TARGET PRICE TO $110 FROM $96

Reuters2026/09/01 10:34

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

-- Earnings Flash (NIC.CN) Delota Corp. Reports Q1 Revenue C$8.3M

MT newswire•2026/09/01 11:18

Indonesia embraces adaptive rules as digital-asset innovation accelerates

Cointelegraph•2026/09/01 11:15

Kura Oncology to present at Wells Fargo Healthcare Conference

Reuters•2026/09/01 11:15

Descartes Systems Acquires Extensiv for $120M, Satisfied From Cash on Hand >DSGX

Dow Jones•2026/09/01 11:15